Topics
Cancer
Improving quality in prostate cancer
Quality indicators can provide reassurance that cancer care is achieving the predicted outcomes
Paul S Craft MB BS, FRACP, MPH
Forsaking cures for cancer: why are we discarding the tumour biospecimens of most patients?
Discarding patients’ cancer samples because of problems with consent processes forgoes potential advances in cancer research, ignores public intent and squanders unique bioresources
Craig Gedye MB ChB, FRACP, PhD · Jennifer Fleming BA, MHA, PhD
What is new in the surgical management and prevention of breast cancer?
Major changes are occurring in breast surgery to help improve quality-of-life outcomes for women who survive breast cancer
Andrew J Spillane MD, FRACS
Quality of care achievements of the Prostate Cancer Outcomes Registry–Victoria
The performance of the Victorian health system has improved according to three processes of care indicators
Fanny Sampurno BA, BSci(Hons) · Arul Earnest PhD, MSc, BSocSc(Hons) · Patabendi B Kumari MB BS, MSc, MD · Jeremy L Millar MB ChB, FRANZCR, FAChPM · Ian D Davis MB BS(Hons), PhD, FRACP · Declan G Murphy FRCS(Urol) · Mark Frydenberg MB BS, FRACS · Paul A Kearns MB BS, FRACS(Urol) · Sue M Evans PhD, MClinEpi
Affordable access to innovative cancer medicines — don’t forget the prices
In addition to providing earlier access to more drugs, we need reform in how new cancer drugs are priced
Narcyz Ghinea BSc(Hons) · Wendy Lipworth MB BS, MSc, PhD
Self-sampling HPV testing versus mainstream cervical screening and HPV testing
A new option would complement the existing screening program, not replace it
Annabelle Farnsworth MB BS(Hons), FRCPA, FIAC
Antioxidant supplementation and cancer patients receiving curative-intent chemotherapy
Antioxidant supplements may compromise chemotherapy dose and should be avoided
Peter J Smith BPharm, Dip Ed, PostGradCertEvidenceBasedCompMed · Kathryn J Steadman BPharm(Hons), PhD
Gene panel testing for hereditary breast cancer
New genetic technology allowing a panel of multiple genes to be tested for mutations may aid risk assessment and management in breast cancer
Ingrid Winship MB ChB, MD, FRACP · Melissa C Southey PhD, FHGSA, FFSc RCPA
Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program
HPV self-collection may improve outcomes for underscreened women, but joining the mainstream HPV screening program is better
Megan Smith MPH, BE · Jie Bin Lew BSc(Bioinformatics), MPH · Kate Simms PhD · Karen Canfell DPhil
Comparing colorectal cancer treatment and survival for Aboriginal and non-Aboriginal people in New South Wales
NSW Aboriginal people with colorectal cancer had lower 5-year survival rates than non-Aboriginal people
Kristie Weir BSc · Rajah Supramaniam BSc, MPH(Hons) · Alison Gibberd MStat · Anthony Dillon PhD · Bruce K Armstrong DPhil, FRACP, FAFPHM · Dianne L O'Connell BMaths(Hons), PhD
Developing competence in biostatistics and research methodology during medical specialty training
Do we equip junior specialists with the skills to conduct research throughout their careers?
Sandra L Turner MB BS(Hons), FRANZCR · Tim Shaw BSc(Hons), PhD
Timeliness of lung cancer care in Victoria: a retrospective cohort study
Interventions that improve timeliness and appropriateness of care have produced impressive results
Sue M Evans PhD, MClinEpi · Arul Earnest PhD, MSc, BSocSc(Hons) · Wendy Bower PhD, BAppSc(Physio), PgDEpiBiost · Meera Senthuren BSc(Hons) · Peta McLaughlin BApplSci · Rob Stirling BSc(Hons), MB BCh(Hons), FRACP
Lung cancer screening in Australia: progress or procrastination?
The challenge facing Australia is the translation of international results on lung cancer screening into sustainable, cost-effective clinical practice
Fraser Brims MD, MRCP, FRACP · Annette McWilliams MB BS, FRACP, FRCPC · Kwun Fong MB BS, PhD, FRACP
Cost-effectiveness of screening for bowel cancer
Increased treatment costs of bowel cancer are a stimulus for considerable effort in the areas of prevention and early detection
Terry D Bolin MD, FRACP, FRCP · Melvyn G Korman MB BS(Hons), PhD, FRACP · Fiona Nicholson MB BS, FRACP, PhD · Lynne Pezzullo BEc(Hons) · Jeffrey Engelman MB BS(Hons), MD, FRACP · Katherine Collings BScNutr(Hons), MScDiet · David Gilchrist Creelman BEc, BCom
Not just a cosmetic problem: facial papules in Birt-Hogg-Dubé syndrome
A combination of multiple facial papules, spontaneous pneumothorax and a personal or family history of renal cell carcinoma should trigger consideration of BHD
Ludi Ge MB BS(Hons) · Patricia Lowe MB BS(Hon), MMed, FACD
Studying the Thenar Eminence of Amateur cooKs (STEAK) study: a double-blinded, cross-sectional study
Manual assessment of steak doneness is possible — but don’t bet your life on it
Toby I Vinycomb MB BS, BMedSc(Hons) · Amanda M-Y Tan MB BS(Hons), BMedSc(Hons) · Manu Bhatnagar MB BS · Joon Ming Wong MB BS, BEng(Civil)
The Value of Audio Devices in the Endoscopy Room (VADER) study: a randomised controlled trial
May the Force be with you in the endoscopy room
Zaid SM Ardalan MB ChB · Abhinav Vasudevan MB BS · Simon Hew MB BS · Julien Schulberg MB BS, BMedSci · Steve Lontos MB BS, FRACP, MD
Routine integration of palliative care: what will it take?
Palliative care not only requires access to quality services but also physicians’ willingness to have difficult conversations with patients
Jennifer Philip PhD, FAChPM, MMed · Anna Collins MHealthPsych, BSci(Psych)
Reassessing rare cancers
Ovarian cancer shows how genetic subtyping allows similarities between cancers to guide treatment trials
Ian N Olver MB BS, MD, PhD
The challenges of early diagnosis of cancer in general practice
Managing missed opportunities when most cancer symptoms are only weakly predictive
Jon D Emery MB BCh, FRACGP, DPhil
Advances in radiation therapy
Advances in radiation therapy have resulted in more precise and effective treatments with fewer side effects
Dion F Forstner MB BS(Hons), FRANZCR · Mei Ling Yap MB BS, BSc(Med), FRANZCR
Life expectancy discussions in a multisite sample of Australian medical oncology outpatients
Advising patients with cancer about life expectancy must be tailored to their individual desire for information
Alison C Zucca BA(Hons), MMedSc · Rob W Sanson-Fisher BPsych(Hons), MPsych, PhD · Amy Waller BA(Hons), PhD · Mariko Carey DPsych(Health), BSc(Hons) · Alice Grady BPsych · Lisa Mackenzie BPsych(Hons), PhD
Do teleoncology models of care enable safe delivery of chemotherapy in rural towns?
High-quality cancer care can be provided at rural centres by teleoncology models
Bryan A Chan BPharm(Hons), MB BS(Hons), FRACP · Sarah L Larkins MB BS, PhD, FRACGP · Rebecca Evans BSp · Kerrianne Watt PhD · Sabe Sabesan BM BS, FRACP, PhD
The dangers of diagnosing cystic neck masses as benign in the era of HPV-associated oropharyngeal cancer
Metastatic lymphadenopathy as the primary provisional diagnosis in adults with cystic neck masses
Chris Wratten MB BS, BMedSci, FRANZCR · Sravan Anne · Minh Thi Tieu MB BS, BSc(Med), FRANZCR · Balasubramaniam Kumar MD, DNB, FRANZCR · Robert Eisenberg MB BS, FRACS